Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 24;5(2):ofy023.
doi: 10.1093/ofid/ofy023. eCollection 2018 Feb.

Pulmonary Cavity From Mycobacterium malmoense in an HIV-Infected Patient: Complicated by Bronchopleural Fistula

Affiliations

Pulmonary Cavity From Mycobacterium malmoense in an HIV-Infected Patient: Complicated by Bronchopleural Fistula

Eric Abston et al. Open Forum Infect Dis. .

Abstract

We present a case of M. malmoense and HIV co-infection complicated by aspergilloma leading to bronchopleural fistula with intractable pneumothorax and pleural aspergillosis, ultimately requiring surgical intervention. Treatment guidelines for M. malmoense are reviewed, literature regarding M. malmoense and HIV co-infection is reviewed, and the epidemiology of M. malmoense in North America is discussed.

Keywords: HIV; Mycobacterium malmoense; bronchopleural fistula.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(A) Demonstrates right upper lobe cavitary lesion associated with initial Mycobacterium malmoense infection in tissue previously known to be normal. (B) Shows the same right upper lobe cavitary lesion following mycobacterial therapy with interval development of aspergilloma. Pneumothorax and pleural effusion also seen. (C) Displays interval chest tube placement with bronchopleural fistula. Subcutaneous emphysema from chest tube also observed.

Similar articles

Cited by

References

    1. Warren NG, Body BA, Silcox VA, Matthews JH. Pulmonary disease due to Mycobacterium malmoense. J Clin Microbiol 1984; 20:245–7. - PMC - PubMed
    1. Hoefsloot W, Boeree MJ, van Nieuwkoop C et al. . No human transmission of Mycobacterium malmoense in a perfect storm setting. Eur Respir J 2012; 40:1576–8. - PubMed
    1. Griffith DE, Aksamit T, Brown-Elliott BA et al. ; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Diseases Society of America An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367–416. - PubMed
    1. Murray MP, Laurenson IF, Hill AT. Outcomes of a standardized triple-drug regimen for the treatment of nontuberculous mycobacterial pulmonary infection. Clin Infect Dis 2008; 47:222–4. - PubMed
    1. Jenkins PA, Campbell IA, Banks J et al. . Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. Thorax 2008; 63:627–34. - PubMed

LinkOut - more resources